These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 24185704)

  • 1. Muscleblind-like 1 activates insulin receptor exon 11 inclusion by enhancing U2AF65 binding and splicing of the upstream intron.
    Echeverria GV; Cooper TA
    Nucleic Acids Res; 2014 Feb; 42(3):1893-903. PubMed ID: 24185704
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The protein factors MBNL1 and U2AF65 bind alternative RNA structures to regulate splicing.
    Warf MB; Diegel JV; von Hippel PH; Berglund JA
    Proc Natl Acad Sci U S A; 2009 Jun; 106(23):9203-8. PubMed ID: 19470458
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Muscleblind-like 1 (Mbnl1) promotes insulin receptor exon 11 inclusion via binding to a downstream evolutionarily conserved intronic enhancer.
    Sen S; Talukdar I; Liu Y; Tam J; Reddy S; Webster NJ
    J Biol Chem; 2010 Aug; 285(33):25426-37. PubMed ID: 20519504
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An intron enhancer recognized by splicing factors activates polyadenylation.
    Lou H; Gagel RF; Berget SM
    Genes Dev; 1996 Jan; 10(2):208-19. PubMed ID: 8566754
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autoregulated splicing of muscleblind-like 1 (MBNL1) Pre-mRNA.
    Gates DP; Coonrod LA; Berglund JA
    J Biol Chem; 2011 Sep; 286(39):34224-33. PubMed ID: 21832083
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The U1 small nuclear ribonucleoprotein/5' splice site interaction affects U2AF65 binding to the downstream 3' splice site.
    Côté J; Beaudoin J; Tacke R; Chabot B
    J Biol Chem; 1995 Feb; 270(8):4031-6. PubMed ID: 7876151
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hu antigen R (HuR) functions as an alternative pre-mRNA splicing regulator of Fas apoptosis-promoting receptor on exon definition.
    Izquierdo JM
    J Biol Chem; 2008 Jul; 283(27):19077-84. PubMed ID: 18463097
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanisms for U2AF to define 3' splice sites and regulate alternative splicing in the human genome.
    Shao C; Yang B; Wu T; Huang J; Tang P; Zhou Y; Zhou J; Qiu J; Jiang L; Li H; Chen G; Sun H; Zhang Y; Denise A; Zhang DE; Fu XD
    Nat Struct Mol Biol; 2014 Nov; 21(11):997-1005. PubMed ID: 25326705
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protein 4.1R Exon 16 3' Splice Site Activation Requires Coordination among TIA1, Pcbp1, and RBM39 during Terminal Erythropoiesis.
    Huang SC; Zhang HS; Yu B; McMahon E; Nguyen DT; Yu FH; Ou AC; Ou JP; Benz EJ
    Mol Cell Biol; 2017 May; 37(9):. PubMed ID: 28193846
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polypyrimidine tract binding protein blocks the 5' splice site-dependent assembly of U2AF and the prespliceosomal E complex.
    Sharma S; Falick AM; Black DL
    Mol Cell; 2005 Aug; 19(4):485-96. PubMed ID: 16109373
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human GC-AG alternative intron isoforms with weak donor sites show enhanced consensus at acceptor exon positions.
    Thanaraj TA; Clark F
    Nucleic Acids Res; 2001 Jun; 29(12):2581-93. PubMed ID: 11410667
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Splicing Enhancers at Intron-Exon Borders Participate in Acceptor Splice Sites Recognition.
    Kováčová T; Souček P; Hujová P; Freiberger T; Grodecká L
    Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32911621
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of MBNL1 and MBNL3 domains required for splicing activation and repression.
    Grammatikakis I; Goo YH; Echeverria GV; Cooper TA
    Nucleic Acids Res; 2011 Apr; 39(7):2769-80. PubMed ID: 21109529
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of exonic regions involved in nuclear localization, splicing activity, and dimerization of Muscleblind-like-1 isoforms.
    Tran H; Gourrier N; Lemercier-Neuillet C; Dhaenens CM; Vautrin A; Fernandez-Gomez FJ; Arandel L; Carpentier C; Obriot H; Eddarkaoui S; Delattre L; Van Brussels E; Holt I; Morris GE; Sablonnière B; Buée L; Charlet-Berguerand N; Schraen-Maschke S; Furling D; Behm-Ansmant I; Branlant C; Caillet-Boudin ML; Sergeant N
    J Biol Chem; 2011 May; 286(18):16435-46. PubMed ID: 21454535
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A targeted oligonucleotide enhancer of SMN2 exon 7 splicing forms competing quadruplex and protein complexes in functional conditions.
    Smith LD; Dickinson RL; Lucas CM; Cousins A; Malygin AA; Weldon C; Perrett AJ; Bottrill AR; Searle MS; Burley GA; Eperon IC
    Cell Rep; 2014 Oct; 9(1):193-205. PubMed ID: 25263560
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MBNL1 binds GC motifs embedded in pyrimidines to regulate alternative splicing.
    Goers ES; Purcell J; Voelker RB; Gates DP; Berglund JA
    Nucleic Acids Res; 2010 Apr; 38(7):2467-84. PubMed ID: 20071745
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MBNL1 is the primary determinant of focus formation and aberrant insulin receptor splicing in DM1.
    Dansithong W; Paul S; Comai L; Reddy S
    J Biol Chem; 2005 Feb; 280(7):5773-80. PubMed ID: 15546872
    [TBL] [Abstract][Full Text] [Related]  

  • 18. YB-1 binds to CAUC motifs and stimulates exon inclusion by enhancing the recruitment of U2AF to weak polypyrimidine tracts.
    Wei WJ; Mu SR; Heiner M; Fu X; Cao LJ; Gong XF; Bindereif A; Hui J
    Nucleic Acids Res; 2012 Sep; 40(17):8622-36. PubMed ID: 22730292
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intron removal requires proofreading of U2AF/3' splice site recognition by DEK.
    Soares LM; Zanier K; Mackereth C; Sattler M; Valcárcel J
    Science; 2006 Jun; 312(5782):1961-5. PubMed ID: 16809543
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HnRNP L-mediated regulation of mammalian alternative splicing by interference with splice site recognition.
    Heiner M; Hui J; Schreiner S; Hung LH; Bindereif A
    RNA Biol; 2010; 7(1):56-64. PubMed ID: 19946215
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.